Upcoming Webinars

https://biopharmawebinars.com/webinars/regulatory-challenges-of-recent-low-endotoxin-recovery-regulatory-queries-pfizers-strategy-to-evaluate-and-implement-global-changes-to-meet-evolving-expectations/

Regulatory Challenges of Recent Low Endotoxin Recovery Regulatory Queries: Pfizer’s Strategy to Evaluate and Implement Global Changes to Meet Evolving Expectations

Presented by Jody Peraino MS, Principal Scientist, Pfizer, Allen L. Burgenson, Global Subject Matter Expert, Testing Solutions at Lonza
20th March 2026


https://biopharmawebinars.com/webinars/navigating-the-2025-iso-109931-revision/

Navigating the 2025 ISO 10993‑1 Revision

Presented by Elisabet Jamez, Expert Advisory Services team at Nelson Labs and Wouter Buyssens, Scientific Project Manager at Nelson Labs
31st March 2026


https://biopharmawebinars.com/webinars/validating-rcr-on-a-microfluidic-platform-a-multi-matrix-approach/

Validating rCR on a Microfluidic Platform: A Multi-Matrix Approach

Presented by Meg Provenzano, Global Product Manager for Endotoxin at Veolia
14th April 2026


https://biopharmawebinars.com/webinars/automation-traceability-reliability-see-our-lims-in-action/

Automation, Traceability, Reliability: See Our LIMS in Action

Presented by Albane Flocon, Bioinformatics developer at genOway, Christel Merrouche, Head of preclinical processes at genOway and Stéphane Pitout -  Director of Professional Sales (SciY)
22nd April 2026


 

On Demand Webinars

https://biopharmawebinars.com/webinars/considerations-for-mrna-lnp-potency-assay-development-for-gene-editing-products/

Considerations for mRNA-LNP Potency Assay Development for Gene Editing Products

Presented by Benjamin Hall, Associate Director in Analytical Development at Tessera Therapeutics, Gargi Chaudhuri, Ph.D., Senior Field Applications Scientist, Bio-Techne (Protein Simple) 
12th March 2026


https://biopharmawebinars.com/webinars/expanding-continuous-manufacturing-at-pfizer-enabling-high-drug-load-formulations-via-wet-granulation-technology/

Expanding Continuous Manufacturing at Pfizer, Enabling High Drug Load Formulations via Wet Granulation Technology

Presented by Travis Powell, Senior Principal Scientist at Pfizer
10th March 2026


https://biopharmawebinars.com/webinars/addressing-subvisible-silicone-oil-droplets-industry-challenges-analytical-strategies-and-usps-rationale-for-a-new-general-informational-chapter/

Addressing Subvisible Silicone Oil Droplets-Industry Challenges, Analytical Strategies, and USP’s Rationale for a New General Informational Chapter

Presented by Desmond G Hunt, Senior Principal Scientist at US Pharmacopeia, Laura A. Philips, PhD, MBA President and Chief Executive Officer Spheryx, Inc., Tyler Carter, PhD. Senior Application Scientist, at Yokogawa Fluid Imaging Technologies Inc
04th March 2026


https://biopharmawebinars.com/webinars/developing-a-site-wide-contamination-control-strategy-from-risk-mapping-to-implementation/

Developing a Site-Wide Contamination Control Strategy: From Risk Mapping to Implementation

Presented by Joseph Horvath, PhD, Head of Quality Risk Management at Takeda Pharmaceuticals, Liz Brockson, Aseptic Processing and Sterility Assurance Lead in Global Sterility Assurance and Microbiology at Takeda
02nd March 2026